Published Paper Details:

Swallowing tablets is a significant problem faced by adults and children, causing patients to fail to comply with medication complaints. To solve these problems, we have developed a new type of medicine that dissolves quickly and dissolves in saliva, called rapid-acting tablets. There are many fast-acting preparations on the market today, such as Claritin Reditab (manufacturer R.P. Scherr, Inc.). Risperdal M-Tab (manufactured by Jansen Pharmaceuticals), Tempra Quicklets (manufactured by Cima Labs, Inc.), and the technology is still being developed. Tablets are considered the most popular due to their easy transportation and low production costs, but patient outcomes are poor for children and the elderly with dysphagia. Tablets, capsules and syrups. Various MDDs are marketed, such as orally dissolving tablets and oral film-coated tablets (MDFS). MDF has emerged over the past few years from the food industry and oral care into breathtaking products, becoming a new and widely used product by consumers. The purpose of this review is to investigate the feasibility of rapid elimination of prescription drugs. Once administered, the tablets dissolve or disintegrate in the mouth without additional water to help preserve the active ingredient. Rapidly disintegrating tablets (FDTs) have become more and more in demand over the years and have become a rapidly growing area in the pharmaceutical industry as most tablets dissolve or burst in saliva within 60 seconds.